What are the Historical Developments and Current Growth Metrics of the Monkey Pox Testing Market?
The monkey pox testing market has seen considerable growth due to a variety of factors.
• The monkeypox testing market has shown steady growth in recent years. It will increase from $1.46 billion in 2024 to $1.53 billion in 2025, with a CAGR of 4.8%.
The growth is driven by increased government funding, the need for rapid tests, expanded testing capacity, enhanced research and development, and public awareness campaigns.
What Is The Projected Growth Of The Monkey Pox Testing Template Market?
The monkey pox testing market is expected to maintain its strong growth trajectory in upcoming years.
• The monkey pox testing market is expected to grow to $1.81 billion by 2029 with a CAGR of 4.4%.
This growth is attributed to rising healthcare spending, the development of point-of-care tests, growing use of at-home testing kits, and healthcare infrastructure improvements. Trends include integrating testing with surveillance systems, digital health tools, technological advancements, and research in diagnostics.
What Are The Key Drivers Fueling Growth In The Monkey Pox Testing Market?
The rising incidence of monkeypox disease is expected to contribute to the growth of the monkeypox testing market. Monkeypox, a viral disease, has seen an increase in cases due to factors such as human-to-human transmission, global travel, and the discontinuation of smallpox vaccinations. Testing is vital to identify infected individuals, allowing for timely treatment and preventing further transmission. For instance, the European Centre for Disease Prevention and Control reported 1,152 suspected monkeypox cases in early 2022, with a case-fatality rate of 4.8%. Consequently, the rise in monkeypox cases is driving the demand for monkeypox testing.
What Are The Principal Market Segments In The Global Monkey Pox Testing Industry?
The monkey pox testing market covered in this report is segmented –
1) By Technology: Polymerase Chain Reaction (PCR), Lateral Flow Assay (LFA), Other Technologies
2) By Mode: Laboratory Testing, Point Of Care Testing
3) By End-Use: Hospitals And Clinics, Diagnostic Laboratories, Other End-Uses
Subsegments:
1) By Polymerase Chain Reaction (PCR): Real-Time PCR (qPCR), Reverse Transcription PCR (RT-PCR), Multiplex PCR
2) By Lateral Flow Assay (LFA): Immunochromatographic Lateral Flow Assays, Rapid Antigen Detection Kits
3) By Other Technologies: ELISA (Enzyme-Linked Immunosorbent Assay), CRISPR-based Testing, Serological Tests (Antibody Detection), Nucleic Acid Sequence-Based Amplification (NASBA)
Pre-Book The Monkey Pox Testing Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Trends Are Shaping The Monkey Pox Testing Market?
Prominent firms in the monkey pox testing industry are honing their focus on the advancement of diagnostic methods such as saliva-based tests, aiming for improved precision, convenience, and availability. The use of saliva samples in identifying the monkeypox virus is the basis of such saliva-based tests. For example, Flow Health, a US medical lab, introduced the saliva-based (polymerase chain reaction) PCR monkeypox test in July 2022. The introduction of this test has transformed the procedure of testing, offering a less invasive and more comfortable method for detecting the virus. This distinctive exam boasts high specificity and sensitivity, rapid amplification of genetic content, and compatibility with diverse applications. This test offers quantitative assessment of viral proportions and identifies pathogens directly, whilst also making sample gathering much easier. Notably, it enables testing before physical symptoms appear, vital for quick identification and curtailing virus dissemination.
Who Are the Key Players In The Monkey Pox Testing Market?
Major companies operating in the monkey pox testing market are:
• F. Hoffmann-La Roche AG
• Thermo Fisher Scientific Inc.
• Abbott Laboratories
• Becton Dickinson and Company
• Mayo Clinic Laboratories
• Laboratory Corporation of America Holdings
• Quest Diagnostics Incorporated
• Sonic Healthcare Limited
• bioMérieux S.A.
• Bio-Rad Laboratories Inc.
• QIAGEN N.V.
• Cepheid Inc.
• Aegis Sciences Corporation
• Chembio Diagnostics Inc.
• Flow Health Inc.
• SeraCare Life Sciences Inc.
• BioGX Inc.
• Applied DNA Sciences Inc.
• CerTest Biotec S.L.
• Altona Diagnostics GmbH
• Creative Biogene Inc.
• ACON Biotech (Hangzhou) Co Ltd.
What Are The Regional Insights Into The Monkey Pox Testing Market?
North America was the largest region in the monkey pox testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the monkey pox testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
